{"entity":{"type":"insider","cik":"0001872564","url":"/insider/0001872564","json_url":"/insider/0001872564.json","name":"Burroughs Amy L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2021-08-17","last":"2026-03-17","span_basis":"filed_date"},"name_variants":[{"name":"Burroughs Amy L.","source":"filing","n_filings":8,"first_seen":"2021-08-17","last_seen":"2026-03-17"}],"transactions":[{"id":6032437,"accession":"0001872564-26-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001872564-26-000008","line_url":"/filing/0001872564-26-000008","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14583.0,"shares_display":"14,583","price_per_share":46.70563410135089,"price_display":"46.71","price_state":"stated","total_value":681108.2621,"total_display":"681,108.26","total_whole":"681,108","shares_owned_after":291746.0,"shares_owned_after_display":"291,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider","n_lines":2},{"id":5900471,"accession":"0001872564-26-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001872564-26-000006","line_url":"/filing/0001872564-26-000006","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14583.0,"shares_display":"14,583","price_per_share":39.19489002948639,"price_display":"39.19","price_state":"stated","total_value":571579.0813,"total_display":"571,579.08","total_whole":"571,579","shares_owned_after":293059.0,"shares_owned_after_display":"293,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider","n_lines":3},{"id":6181443,"accession":"0001872564-26-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001872564-26-000004","line_url":"/filing/0001872564-26-000004","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68749.0,"shares_display":"68,749","price_per_share":37.07112577637493,"price_display":"37.07","price_state":"stated","total_value":2548602.826,"total_display":"2,548,602.83","total_whole":"2,548,603","shares_owned_after":296497.0,"shares_owned_after_display":"296,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-16","scope":"insider","n_lines":2},{"id":5889258,"accession":"0001872564-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001872564-26-000002","line_url":"/filing/0001872564-26-000002#line-3","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71339.0,"shares_display":"71,339","price_per_share":38.103,"price_display":"38.10","price_state":"stated","total_value":2718229.917,"total_display":"2,718,229.92","total_whole":"2,718,230","shares_owned_after":138976.0,"shares_owned_after_display":"138,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":4651131,"accession":"0001562180-25-005077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-005077","line_url":"/filing/0001562180-25-005077#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23314.0,"shares_display":"23,314","price_per_share":3.8702,"price_display":"3.87","price_state":"stated","total_value":90229.8428,"total_display":"90,229.84","total_whole":"90,230","shares_owned_after":47083.0,"shares_owned_after_display":"47,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-25","filed_date":"2025-06-25","scope":"insider"},{"id":2319247,"accession":"0001562180-24-008254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-008254","line_url":"/filing/0001562180-24-008254#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15450.0,"shares_display":"15,450","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":110467.5,"total_display":"110,467.50","total_whole":"110,468","shares_owned_after":19099.0,"shares_owned_after_display":"19,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-09","scope":"insider"},{"id":4894492,"accession":"0001562180-25-000851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-000851","line_url":"/filing/0001562180-25-000851#line-1","is_derivative":false,"issuer_cik":"0001831363","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001831363","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":510.0,"shares_display":"510","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":2606.1,"total_display":"2,606.10","total_whole":"2,606","shares_owned_after":19609.0,"shares_owned_after_display":"19,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-30","filed_date":"2025-02-03","scope":"insider"},{"id":5509806,"accession":"0001235802-21-000101","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-21-000101","line_url":"/filing/0001235802-21-000101#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001872564","owner_name":"Burroughs Amy L.","owner_display_name":"Burroughs Amy L.","owner_url":"/insider/0001872564","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44950.0,"shares_display":"44,950","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":141592.5,"total_display":"141,592.50","total_whole":"141,593","shares_owned_after":44950.0,"shares_owned_after_display":"44,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831363","name":"Terns Pharmaceuticals, Inc.","url":"/issuer/0001831363","role":"Director, Officer (Chief Executive Officer)","n_filings":7,"first_seen":"2024-12-09","last_seen":"2026-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001401040","name":"DiaMedica Therapeutics Inc.","url":"/issuer/0001401040","role":"Director","n_filings":1,"first_seen":"2021-08-17","last_seen":"2021-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001872564","retrieved_at":"2026-08-25T05:35:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}